100% agree with you. As I have said in a previous post, aGVHD alone is enough to make a company with multiple sources of revenue of multiple billions of dollars. The $2 SP is still very cheap in a year or two for aGVHD alone.
- Forums
- ASX - By Stock
- Ann: End-Stage HF Results Selected For AHA Scientific Sessions
100% agree with you. As I have said in a previous post, aGVHD...
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.0¢ |
Change
-0.060(6.00%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
99.0¢ | 99.5¢ | 93.5¢ | $5.643M | 5.894M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 72266 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 973 | 0.975 |
1 | 1005 | 0.950 |
2 | 1063 | 0.945 |
5 | 22792 | 0.940 |
8 | 37111 | 0.935 |
Price($) | Vol. | No. |
---|---|---|
0.930 | 790 | 1 |
0.940 | 5630 | 4 |
0.945 | 20000 | 1 |
0.950 | 67722 | 2 |
0.955 | 60000 | 2 |
Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online